AD816 Crossover Study
Trial details
- Registry ID
- NCT05793684
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| AD816 Crossover StudyNCT05793684 | Apnimed | Phase 2 | Completed | 2023-11-09Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |